King's College London

Research portal

Cancer discovery, ‎2159-8274

Journal

  1. Ectopic Humanized Mesenchymal Niche in Mice Enables Robust Engraftment of Myelodysplastic Stem Cells

    Mian, S. A., Abarrategi, A., Kong, K. L., Rouault-Pierre, K., Wood, H., Oedekoven, C. A., Smith, A. E., Batsivari, A., Ariza-McNaughton, L., Johnson, P., Snoeks, T., Mufti, G. J. & Bonnet, D., 1 Mar 2021, In: Cancer discovery. 2, 2, p. 135-145 11 p.

    Research output: Contribution to journalArticlepeer-review

  2. HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers

    Li, B. T., Michelini, F., Misale, S., Cocco, E., Baldino, L., Cai, Y., Shifman, S., Tu, H-Y., Myers, M. L., Xu, C., Mattar, M., Khodos, I., Little, M., Qeriqi, B., Weitsman, G., Wilhelm, C. J., Lalani, A. S., Diala, I., Freedman, R. A., Lin, N. U. & 29 others, Solit, D. B., Berger, M. F., Barber, P. R., Ng, T., Offin, M., Isbell, J. M., Jones, D. R., Yu, H. A., Thyparambil, S., Liao, W-L., Bhalkikar, A., Cecchi, F., Hyman, D. M., Lewis, J. S., Buonocore, D. J., Ho, A. L., Makker, V., Reis-Filho, J. S., Razavi, P., Arcila, M. E., Kris, M. G., Poirier, J. T., Shen, R., Tsurutani, J., Ulaner, G. A., de Stanchina, E., Rosen, N., Rudin, C. M. & Scaltriti, M., 1 May 2020, In: Cancer discovery. 10, 5, p. 674-687 14 p.

    Research output: Contribution to journalArticlepeer-review

  3. First-in-human phase i study of fisogatinib (BLU-554) validates aberrant FGF19 signaling as a driver event in hepatocellular carcinoma

    Kim, R. D., Sarker, D., Meyer, T., Yau, T., Macarulla, T., Park, J. W., Choo, S. P., Hollebecque, A., Sung, M. W., Lim, H. Y., Mazzaferro, V., Trojan, J., Zhu, A. X., Yoon, J. H., Sharma, S., Lin, Z. Z., Chan, S. L., Faivre, S., Feun, L. G., Yen, C. J. & 15 others, Dufour, J. F., Palmer, D. H., Llovet, J. M., Manoogian, M., Tugnait, M., Stransky, N., Hagel, M., Kohl, N. E., Lengauer, C., Sherwin, C. A., Schmidt-Kittler, O., Hoeflich, K. P., Shi, H., Wolf, B. B. & Kang, Y. K., 1 Dec 2019, In: Cancer discovery. 9, 12, p. 1696-1707 12 p.

    Research output: Contribution to journalArticlepeer-review

  4. E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer

    Bajrami, I., Marlow, R., van de Ven, M., Brough, R., Pemberton, H. N., Frankum, J., Song, F., Rafiq, R., Konde, A., Krastev, D. B., Menon, M., Campbell, J., Gulati, A., Kumar, R., Pettitt, S. J., Gurden, M. D., Cardenosa, M. L., Chong, I., Gazinska, P., Wallberg, F. & 11 others, Sawyer, E. J., Martin, L-A., Dowsett, M., Linardopoulos, S., Natrajan, R., Ryan, C. J., Derksen, P. W. B., Jonkers, J., Tutt, A. N. J., Ashworth, A. & Lord, C. J., 4 Apr 2018, In: Cancer discovery. 8, 4, p. 498-515

    Research output: Contribution to journalArticlepeer-review

  5. Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma

    Jafri, M., Wake, N. C., Ascher, D. B., Pires, D. E. V., Gentle, D., Morris, M. R., Rattenberry, E., Simpson, M. A., Trembath, R. C., Weber, A., Woodward, E. R., Donaldson, A., Blundell, T. L., Latif, F. & Maher, E. R., Jul 2015, In: Cancer discovery. 5, 7, p. 723-9 7 p.

    Research output: Contribution to journalArticlepeer-review

  6. Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers

    Watkins, J., Weekes, D., Shah, V., Gazinska, P., Joshi, S., Sidhu, B., Gillett, C., Pinder, S., Vanoli, F., Jasin, M., Mayrhofer, M., Isaksson, A., Cheang, M. C. U., Mirza, H., Frankum, J., Lord, C. J., Ashworth, A., Vinayak, S., Ford, J. M., Telli, M. L. & 2 others, Grigoriadis, A. & Tutt, A. N. J., 1 May 2015, In: Cancer discovery. 5, 5, p. 488-505 18 p.

    Research output: Contribution to journalArticlepeer-review

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454